European Commission signs third contract with BioNTech-Pfizer for 1.8bn vaccine doses
- The contract reserves the doses on behalf of all European Union member states, between end 2021 to 2023, the statement added. The contract requires that the vaccine production is based in the EU and that essential components are sourced from the EU.